Patent ID: 8802161

Claim:
A pharmaceutical composition useful for treating or reducing the risk of cancer comprising: a) frankincense ( Boswellia carteri ) b) at least one tumoricidal agent selected from the group consisting of beth root ( Trillium pendulum root), galbanum ( Ferula galbaniflua ), and wild yam ( Dioscorea villosa ), c) at least one anti-proliferative herb comprising speranskia herb ( Speranskia tuberculata ) and; d) at least one lactic acid dehydrogenase inhibitor herein termed “LDH (−)” comprising at least one of cinnamon ( Cinnamomum cassia ) or 2′,3,4′,5,7-pentahydroxyflavone (morin), and e) a pharmaceutically acceptable carrier wherein the total amount of component a) is 5-20% by wt of the total composition, the total amount of component b) is 5-20% by wt of the total composition, and wherein component c) is present in a total amount of up to 8% by wt of the total composition.